No one ever claimed investing in the biotech industry was a smooth ride, but for shareholders of Viking Therapeutics (NASDAQ: VKTX), the turbulence has been extremely challenging thus far.

Shares of Viking Therapeutics have sold off sharply as the market awaits updates on its drug candidates. The company is preparing for the possible FDA approval of its weight loss drug candidate ...

Looking for help with today's NYT Strands puzzle? Here's an extra hint to help you uncover the right words, as well as all of today's answers and Spangram. Looking for help with today's NYT ...

No one knows Washington secrets like Paul Bedard. This longtime D.C. reporter joined the Washington Examiner in 2012 after penning U.S. News & World Report's premiere political column ...

It has been roughly 3 months since my last Viking Therapeutics, Inc. (NASDAQ:VKTX) article, where I discussed how VKTX had dropped 50% despite strong clinical progress in obesity and NASH due to ...

Viking Therapeutics, Inc. (NASDAQ:VKTX) is gearing up to initiate a phase 3 study using its subcutaneous formulation of its candidate VK2735 for the treatment of patients with obesity. It is ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

THE WORLD IS loud and fast and demanding, and to combat this, Paul Skenes forages for silence. He relishes the moments where the chaos gives way to blissful nothingness, just him and dead air.

Unfortunately, what's good news for Eli Lilly is probably bad news for investors in Novo Nordisk and Viking Therapeutics, both of which lag Lilly in the race to develop their own easy-to-take GLP ...

Paul Chan Mo-po is Hong Kong's financial secretary. An accountant and the former president of the Hong Kong Institute of Certified Public Accountants (HKICPA), he was appointed development ...

The new additions to the week’s exciting agenda are the 8th International Conference on Education Quality and the HIMSS Executive Summit 2025. These events reflect DFF’s efforts to enhance ...

Why does God allow suffering? In this column we will consider Paul’s inward focus, the way in which he sees himself, through his suffering, as participating in salvation, especially the Passion ...